Benitec Biopharma (BNTC) Current Leases (2020 - 2025)
Benitec Biopharma (BNTC) has disclosed Current Leases for 6 consecutive years, with $346000.0 as the latest value for Q1 2025.
- Quarterly Current Leases rose 18.49% to $346000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $346000.0 through Mar 2025, up 18.49% year-over-year, with the annual reading at $284000.0 for FY2024, 3.27% up from the prior year.
- Current Leases hit $346000.0 in Q1 2025 for Benitec Biopharma, up from $211000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $346000.0 in Q1 2025 to a low of $194000.0 in Q3 2021.
- Historically, Current Leases has averaged $254750.0 across 5 years, with a median of $260500.0 in 2022.
- Biggest five-year swings in Current Leases: soared 32.99% in 2022 and later decreased 24.64% in 2024.
- Year by year, Current Leases stood at $213000.0 in 2021, then grew by 23.47% to $263000.0 in 2022, then rose by 8.75% to $286000.0 in 2023, then decreased by 26.22% to $211000.0 in 2024, then skyrocketed by 63.98% to $346000.0 in 2025.
- Business Quant data shows Current Leases for BNTC at $346000.0 in Q1 2025, $211000.0 in Q3 2024, and $284000.0 in Q2 2024.